Houston Methodist
D

Fatty Liver Disease: Evaluation in the Primary Care Setting

By Houston Methodist FEATURING David W. Victor III
By Houston Methodist FEATURING David W. Victor III
3,171 views
September 21, 2021
Comments 2
Login to view comments. Click here to Login

Related Videos

25:25

NASH Update 2023

Icahn School of Medicine at Mount Sinai

M. B. Bansal

176 views
25:53

Non-Alcoholic Fatty Liver Disease: Where Are We in 2023?

Houston Methodist

N. Gunn

1.8K views
17:22

Treating NASH 2023: Current and Near Future Treatments

UCLA Health

J. Singh

64 views
31:07

Risk Stratification and Management of Non-Alcoholic Fatty Liver Dise…

University of Kansas Medical Center

F. Kanwal

773 views
29:32

NAFLD/NASH: Current Treatment Strategies

CME Outfitters

R. Loomba

1.8K views
32:17

How and Whom to Screen for NAFLD/NASH? Which Are the High-Risk Group…

Cardiometabolic Health Congress (CMHC)

F. Kanwal

502 views
32:08

Understanding NASH: Prevention and Treatment

Houston Methodist

D. W. Victor III

1.2K views
18:47

Advances in NASH/NAFLD

Stanford Medicine

N. J. Torok

1.0K views
36:03

Non Alcoholic Fatty Liver Disease (NAFLD): What’s New and Impact of …

Houston Methodist

V. Ankoma-Sey

554 views
25:36

Primary Care Approach to NAFLD

University of Texas Southwestern Medical Center

M. Kubiliun

454 views
21:28

Updates in NAFLD/NASH Diagnosis and Management: Pharmacological and …

UChicago Medicine: Sixth Annual Updates in Digestive Diseases

M. Charlton

337 views
12:02

Chronic Liver Diseases Q&A

Stanford Medicine

A. Kwong, N. J. Torok, P. Nkechinyere Dike, P. Y. Kwo, T. Tara Ghaziani, R. Dhanasekaran

223 views
38:17

NASH Management 2021 Update: What Is the Effect of Antidiabetic Medi…

Cardiometabolic Health Congress (CMHC)

K. Cusi

1.0K views
20:40

The Rise of Pediatric Non-Alcoholic Fatty Liver Disease: What Are th…

Cardiometabolic Health Congress (CMHC)

S. Xanthakos

322 views
09:33

2021 NASH Management Update: Do We Have Any Approved Therapies? What…

Cardiometabolic Health Congress (CMHC)

C. Mantzoros

343 views
29:12

2021 Update on NASH Management: Current and Future Treatment Options

Houston Methodist

V. Ratziu

154 views
29:13

Lipotoxicity and NAFLD: The Overlooked Complication of T2DM

World Congress Insulin Resistance and Cardiovascular Disease

161 views
05:38

50 y/o Male With Obesity, Pre-DM, HTN, HLD, Mild AST/ALT 2x ULN, BMI…

University of Colorado Department of Medicine

A. Wieland

185 views
17:45

Debate: Which Class of Drug is the Best Treatment for NASH?

Scripps Health

J. Frias, R. Loomba

591 views
27:31

NAFLD/NASH: Noninvasive Diagnostic Testing

CME Outfitters

M. Noureddin

677 views
AUTOPLAY